Adrenna final results February 2017
Revenue for the year increased to R26.2 million (2016: R23.2 million). Operating income before interest and revaluations was higher at R16.2 million (2016: R14.6 million). Total comprehensive income attributable to ordinary shareholders shot up to R21.1 million (2016: R7.9 million). In addition, headline earnings per share was recorded at 13.1 cents per share (2016: 11.9 cents per share)
Dividends per share
No dividends were declared during the current or prior years.
Most read today
Most read yesterday